Curet Myriam's Form 4 filing
Intuitive Surgical Inc (ISRG) · filed Mar 3, 2025
- Accession no.
- 0001035267-25-000076
- Filed
- Mar 3, 2025
- Trade date
- Feb 27-Mar 3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.75M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Curet MyriamCIK 0001632901 | Officer (EVP & Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | Common Stock | AGrant or awardAcquired | +5,012 | $0.00 | $0 | 7,766 | Direct | |
| Feb 28, 2025 | Common Stock | MOption exerciseAcquired | +1,002 | $0.00 | $0 | 6,367 | Direct | |
| Feb 28, 2025 | Common Stock | FTax withholdingDisposed | −497 | $563.77 | −$280,193.69 | 5,870 | Direct | |
| Feb 28, 2025 | Common Stock | FTax withholdingDisposed | −2,486 | $563.77 | −$1,401,532.22 | 3,384 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −3,031 | $577.30F5 | −$1,749,796.3 | 353 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Common Stock | MOption exerciseDisposed | −1,002 | $0.00 | $0 | 1,002 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F5
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $573.78 to $582.10 as follows: 562 shares sold at $573.78 ; 300 shares sold at $575 to $575.78; 619 shares sold at $576.35 to $577.20; 1,145 shares sold at $578 to $578.88; 105 shares sold at $579.48 to $579.89;and 300 shares sold at $582.03 to $582.10. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.